当前位置:首页 - 行情中心 - 丰原药业(000153) - 财务分析 - 现金流量表

丰原药业

(000153)

  

流通市值:24.33亿  总市值:24.54亿
流通股本:4.61亿   总股本:4.65亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,476,314,341.291,708,829,372.27874,594,192.563,822,104,543.71
  收到的税费返还10,005,389.948,445,011.797,682,597.3519,314,096.91
  收到其他与经营活动有关的现金67,598,870.6151,827,656.1229,673,107.22211,266,293.02
  经营活动现金流入小计2,553,918,601.841,769,102,040.18911,949,897.134,052,684,933.64
  购买商品、接受劳务支付的现金1,647,539,719.651,208,844,211.72673,812,355.422,713,306,793.06
  支付给职工以及为职工支付的现金293,017,761.75203,363,291.85112,091,578.35396,934,323.05
  支付的各项税费143,350,074.84101,236,577.4342,285,955.87196,031,860.5
  支付其他与经营活动有关的现金326,778,829.91171,985,641.6274,459,110.42627,114,194.41
  经营活动现金流出小计2,410,686,386.151,685,429,722.62902,649,000.063,933,387,171.02
  经营活动产生的现金流量净额143,232,215.6983,672,317.569,300,897.07119,297,762.62
二、投资活动产生的现金流量:
  收回投资收到的现金2,297,858.16--1,400,000
  取得投资收益收到的现金10,153,024.97--8,557,138.8
  处置固定资产、无形资产和其他长期资产收回的现金净额229,066.5824,520.5670406,922.71
  投资活动现金流入小计12,679,949.7124,520.567010,364,061.51
  购建固定资产、无形资产和其他长期资产支付的现金63,518,587.5239,054,628.8930,116,799.8220,605,804.57
  投资支付的现金---60,000,000
  投资活动现金流出小计63,518,587.5239,054,628.8930,116,799.8280,605,804.57
  投资活动产生的现金流量净额-50,838,637.81-39,030,108.39-30,116,129.8-270,241,743.06
三、筹资活动产生的现金流量:
  取得借款收到的现金1,016,850,273.55831,917,291.65390,746,994.031,534,129,075.21
  收到其他与筹资活动有关的现金130,000,000130,000,000130,000,000-
  筹资活动现金流入小计1,146,850,273.55961,917,291.65520,746,994.031,534,129,075.21
  偿还债务支付的现金911,898,552.07591,369,545.51274,325,545.511,234,242,029.58
  分配股利、利润或偿付利息支付的现金68,260,723.1860,688,755.227,080,955.581,164,155.77
  支付其他与筹资活动有关的现金18,245,124.2912,482,148.795,075,610.68155,604,116.33
  筹资活动现金流出小计998,404,399.54664,540,449.52286,482,111.691,471,010,301.68
  筹资活动产生的现金流量净额148,445,874.01297,376,842.13234,264,882.3463,118,773.53
四、汇率变动对现金及现金等价物的影响-109,864.85-60,608.39-15,647.61-17,174.26
五、现金及现金等价物净增加额240,729,587.04341,958,442.91213,434,002-87,842,381.17
  加:期初现金及现金等价物余额128,469,642.69128,469,642.69128,469,642.69216,312,023.86
  期末现金及现金等价物余额369,199,229.73470,428,085.6341,903,644.69128,469,642.69
补充资料:
  净利润-70,277,823.39-94,804,169.89
  资产减值准备-16,975,181.39-33,415,538.92
  固定资产和投资性房地产折旧-50,485,411.11-104,433,142.53
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-50,485,411.11-104,433,142.53
  无形资产摊销-9,034,059.25-16,895,821.21
  长期待摊费用摊销-8,614,110.51-14,592,506.24
  处置固定资产、无形资产和其他长期资产的损失-808.33-326,419.46
  固定资产报废损失-303,459.63-172,125.98
  公允价值变动损失-5,965,593.5-2,650,611.03
  财务费用-15,173,884.68-34,898,880.81
  投资损失--10,453,128.78--8,556,538.8
  递延所得税--7,313,811.97--6,454,122.22
  其中:递延所得税资产减少-15,224,994.92--5,839,575.75
    递延所得税负债增加--22,538,806.89--614,546.47
  存货的减少-18,679,559.98-46,048,966.86
  经营性应收项目的减少--41,102,789.01--52,619,409.65
  经营性应付项目的增加--69,508,109.66--188,351,063.69
  其他-4,368,621.59--
  现金的期末余额-470,428,085.6-128,469,642.69
  减:现金的期初余额-128,469,642.69-216,312,023.86
  现金及现金等价物的净增加额-341,958,442.91--87,842,381.17
公告日期2026-10-292026-08-282026-04-292026-04-29
审计意见(境内)标准无保留意见
TOP↑